Clinical utility of fractional exhaled nitric oxide in severe asthma management

Andrew Menzies-Gow, Adel H. Mansur, Christopher E. Brightling

Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andrew Menzies-Gow, Adel H. Mansur, Christopher E. Brightling. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019



Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Fractional exhaled nitric oxide is associated with more severe asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Same-day repeatability of fractional exhaled nitric oxide in severe asthma
Source: Eur Respir J, 57 (5) 2003391; 10.1183/13993003.03391-2020
Year: 2021



Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006

Experiences of exhaled nitric oxide measurements in diagnostics of occupational asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 281s
Year: 2001

Exhaled nitric oxide and clinical phenotype of childhood asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011


Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review
Source: Eur Respir J 2016; 47: 751-768
Year: 2016



The role of exhaled nitric oxide in the evaluation of chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 794s
Year: 2006

Ambulatory monitoring of exhaled nitric oxide in childhood asthma exacerbation
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012


Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma
Source: Eur Respir J 2010; 35: 1200-1202
Year: 2010


Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008



The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003